Article
Mavacamten stabilizes the auto-inhibited state of two-headed cardiac myosin
2018-03-22
Abstract excerpt
We used transient biochemical and structural kinetics to elucidate the molecular mechanism of mavacamten, an allosteric cardiac myosin inhibitor and prospective treatment for hypertrophic cardiomyopathy. We find that mavacamten stabilizes an auto-inhibited state of two-headed cardiac myosin, not found in the isolated S1 myosin motor fragment. We determined this by measuring cardiac myosin actin-activated and actin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c9bda61a-f0c9-5958-8873-ba2b12189bd2
- DOI
- 10.1101/287425
